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With the profession of pharmacy globally shifting towards more patient-centered 
services than product-centered services, there still remains the question of what the role of the 
pharmacist can be as not only a patient care provider, but also a public health practitioner. As 
one of the most accessible healthcare providers, pharmacists worldwide are exploring how they 
can better protect and promote the health of their communities. While high-income countries 
have more established patient-centered services with public health implications, such as 
vaccinations, disease state management, and lifestyle counseling among others, poor countries 
lack recognition of these services, which can hinder their adoption and spread throughout this 
part of the world. Low to middle-income countries though often are in the greatest need of 
these services where they often face the double burden of both communicable and non-
communicable diseases. Compounding this issue is that not only do poor nations have a higher 
disease burden, but also have a greater shortage of health care workers including pharmacists.  
 There are several areas of need and opportunity for pharmacists in resource-limited 
countries to engage in public health services. With the global health care worker shortage, 
pharmacists can help fulfil roles in primary care and extend their responsibilities to increase 
coverage in gaps of care. Supply chain management is another essential opportunity given the 
unique medication knowledge pharmacists have in combination with their familiarity with 
workflow and operations of a pharmacy. Additionally, medication safety and adherence 
continues to be a significant issue as low to middle-income countries address falsified and 
substandard medications. In order for pharmacists to be engaged in these and other services 
such as immunizations, government and association leaders should assess how pharmacists can 
better be recognized and integrated within the public health infrastructure and systems within 
resource-limited areas.  
INTRODUCTION 
The role of the pharmacist in global public health continues to evolve. Pharmacists 
throughout the world have traditionally been involved in product-oriented services such as 
dispensing or compounding medications. However, there is a global shift that is occurring from 
product-centered to patient-centered and preventative services including disease state 
management, family planning, immunizations, lifestyle counseling, health screenings, and 
health education among others.1 Many of the patient-centered services that pharmacists are 
involved with have public health implications. While these services are more established in 
high-income countries such as the United States, Canada, and the United Kingdom, low and 
middle income countries are beginning to explore and recognize the contributions of 
pharmacists to public health. From health screenings for diabetes and osteoporosis to 
immunizations and health education, pharmacists are positioned to have an impact on the 
health of both patients and communities. Beyond patient-centered services with public health 
implications, pharmacists in both rich and poor countries are also engaged in broader essential 
public health services such as community partnership mobilization and innovative research in 
order to discover and implement new practice models that advance the profession.2  
 In limited resource communities throughout the world there is a need and opportunity 
for pharmacists to be utilized across key global health areas over and above what is currently 
being done. From workforce development to supply chain management and medication safety, 
pharmacists can apply their medication expertise to contribute to gaps in care that align with 
major global health efforts and programs. The role of pharmacists in these global health areas is 
yet to be defined and presents an opportunity to move the profession forward globally in 
establishing pharmacists as health care providers who also serve as public health practitioners.  
EVOLVING ROLE OF THE PHARMACIST IN PUBLIC HEALTH IN HIGH INCOME COUNTRIES 
Traditionally, the role of the pharmacist has focused around product-centered services 
such as compounding and dispending medications. As technological advances in manufacturing 
occurred along with increased consumer demand for medication information, there was a need 
for pharmacists to focus more on patient-centered services as well. As the profession has 
shifted its attention over to patients, more attention has been given to what the role of the 
pharmacist could be within public health. Pharmacists can vaccinate in the United States, 
United Kingdom, and Canada highlighting their role in primary prevention.  In Canada, nearly a 
third of patients surveyed stated that they would not have been vaccinated against influenza if 
it was not provided at their local community pharmacy.3 Tobacco cessation and lifestyle change 
recommendations are often services provided by pharmacists across the world. In a systematic 
review of public health pharmacy services, 83% of participants stated that pharmacists were 
appropriate providers of tobacco cessation services.4 It has been shown that community 
pharmacists had a higher success rate of tobacco cessation counseling compared to general 
practitioners (physicians) and that they were effective in medication adherence for key diseases 
states such as diabetes and cardiovascular disease.5 Additionally, pharmacists and student 
pharmacists frequently hold classes and provide presentations to the community on key 
chronic disease states such as cardiovascular disease and diabetes as well as emerging health 
issues such as pain management and medication disposal.6 
Many of the patient-centered services that pharmacists provide mentioned above are 
considered to be micro-level public health activities that are part of the responsibilities of a 
pharmacist. Currently, there is a lack of participation in macro level engagement such as the 
coordination and planning of a community health program and other high level activities within 
community organizations or government agencies.7 In 2008, the American Society of Health-
System Pharmacists put out a position paper outlining the activities of health-system 
pharmacists that contribute towards public health. These include providing population-based 
care, developing disease prevention and control programs, developing health education policies 
and programs, collaborating with state and local authorities to address emergencies, engaging 
in population-based research, and disseminating new knowledge.8 As part of medication 
reconciliation efforts upon patient admission, pharmacists can design screening programs to 
detect gaps in immunizations as well as collaborate with social workers to detect barriers to 
care. Pharmacists in this setting can also contribute towards the detection and management of 
infectious diseases outbreaks. In addition to health system roles, pharmacists are also 
employed in government agencies. Careers for pharmacists with defined roles in public health 
in the United States are mostly within the U.S Public Health Service (USPHS). Within USPHS, the 
most pharmacists work within the Indian Health Service (47%), followed by the Food and Drug 
Administration (26%), Bureaus of Prisons (14%), and the National Institutes of Health (13%).9 
Pharmacists are capable of being engaged at a higher level within the top ten essential 
public health services as outlined by the Centers for Disease Control and Prevention (CDC). This 
is because pharmacists are one of the most accessible health care providers.10 A study by the 
Royal Pharmaceutical Society of Great Britain estimated that 94% of the population visits a 
pharmacy at least once a year.11 Patients can walk into pharmacies often at any time of the day 
or night and receive professional advice without an appointment or paying a fee. With reduced 
barriers to care, vulnerable populations are able to find quality health services that they 
otherwise may not be able to have. There are often behavioral as well as financial barriers that 
prevent patients from picking up and adhering to their medications. The National Coalition for 
Prescription Information Education found that 50-60% of medications to treat chronic 
conditions are not taken as prescribed.12 These issues are often not assessed at the point of 
physician diagnosis and can be addressed by community pharmacists who often refer patients 
to medication assistance programs or help patients adhere to their medications through 
techniques such as motivational interviewing.13  
In 2012, the CDC published a program guide on how health care professionals should 
collaborate with pharmacists for the control and prevention of chronic diseases.14 Just as 
pharmacists are part of team-based care plans, pharmacists should be part of program planning 
teams given the fact that nearly 45% of Americans take at least one prescription medication 
and that people with chronic conditions account for 91% of all prescriptions filled.15 To help 
facilitate these collaborative efforts, the CDC guide recommends using the Community Tool 
Box, a free online resource for community health development, as well as the CDC’s Framework 
for Program Evaluation.16 In a commissioned report by Public Health England, it too 
recommends that community organizations and other healthcare professionals partner with 
pharmacists for the effective planning of public health services.5  
ROLE OF THE PHARMACIST IN PUBLIC HEALTH – LOW INCOME COUNTRIES 
The role of the pharmacist in public health activities is not limited to those in wealthier 
nations. The WHO currently recommends 1 pharmacist per 2000 population recognizing the 
contributions pharmacists can make to public health worldwide.17 Although the role of the 
pharmacist in global public health is not as established as it is for other health disciplines such 
as medicine and nursing, pharmacists are positioned to make a difference in global health.18  As 
in the United States, pharmacists in developing countries are often one of the most accessible 
health care professionals in communities and are positioned to advise on chronic disease state 
and lifestyle management. Low income countries are increasingly facing the double burden of 
both communicable and non-communicable diseases where over 75% of deaths due to non-
communicable diseases are attributed to developing countries.19 Although non-communicable 
diseases are recognized by the WHO and others as a global health priority, less than 2% of 
global health funding currently goes towards NCDs.20 In 2013 the WHO developed the Global 
Action Plan for Noncommunicable Diseases with one of the goals having each country achieve 
at least 80% access to essential medications for NCDs.21 There has also been the development 
of the Non-Communicable Disease Alliance which pharmacists can be part of. Pharmacy 
services such as disease state management and patient wellness programs have been shown to 
be cost effective in several developed countries with the potential for this to be translated to 
limited resource environments.22  
The most evident forms of public health participation by pharmacists in LMICs  are 
occurring in community pharmacy settings. Community pharmacists in Sudan are actively 
providing a variety of patient-centered services such as diet and lifestyle counseling, tobacco 
cessation, contraception, and obesity and weight reduction.23 In Zimbabwe, supply chain 
management, health information provision, and chronic disease state management were cited 
as public health activities pharmacists are engaged in.24 Zimbabwe pharmacists also view the 
provision of medications to vulnerable populations as a public health activity associated with 
their ability to manage the supply change and procure the right medications for the right 
patients.24 Based on interviews of pharmacists in Zimbabwe though, there are concerns 
regarding the quality and consistency of these services. In Nigeria, 94% of surveyed pharmacists 
felt that it was acceptable to be engaged in public health activities.25 In Ethiopia, community 
pharmacists stated that the public health services they were involved with most were 
management and screening of infectious diseases, STD partner counseling, and antimicrobial 
stewardship.26  These increased efforts by pharmacists in developing countries to expand into 
public health is supported by the WHO concept of a 7 star pharmacist of which one of the stars 
is “being a lifelong learner reinforcing the complementary aspects between the fields of 
pharmacy and public health”.27  
 In addition to these opportunities that are common to both high and low income 
countries, there are some areas unique to LMICs in which pharmacists can play an important 
role. Some of these are mentioned below.  
WORKFORCE DEVELOPMENT 
Workforce capacity has been identified as one of several factors that enable the 
implementation of pharmacy services in resource-limited settings.28 By 2035 it is projected that 
there will be a global health care workforce shortage of 12.9 million people, including 
pharmacists.29 This translates into nearly 1 billion people not having access to a trained health 
worker.30 While much focus is put on physicians, nurses, and community health workers in 
filling the gap of the health workforce shortage, there is little effort to recognize pharmacists as 
a contributor towards the solution given their training and accessibility. Eighty five percent of 
WHO member states report having less than 1 pharmaceutical personnel per 1000 
population.31 Developing countries are impacted the most by this shortage of qualified 
pharmaceutical personnel across both community and health system sectors.32 Countries such 
as Zambia, Uganda, and Ethiopia report having less than 3 pharmacists per 100,000 people 
compared to 88 pharmacists per 100,000 in the US.28 A study assessing the necessary human 
resources required for scaling up highly active antiretroviral therapy in Malawi identified 
pharmacists as the health profession cadre needed the most for the program to be effective.33 
Another key issue in attaining an equitable and sustainable workforce is the appropriate 
distribution of health care workers in both urban and rural settings. A systematic review of the 
pharmacy workforce found that there is a lack of pharmacists in rural compared to urban 
settings.34 Retention strategies are needed to place pharmacists in rural areas so that patients 
have equitable access to care.  
One of the focus areas within the Global Strategy on Human Resource for Health is the 
need for more and higher quality education.35 To help facilitate the discussion of advancing 
pharmacy education across sub-Saharan Africa, a UNESCO-Unitwin grant supported the 
development of the African Centre of Excellence in Pharmacy Education consisting of Ghana, 
Nigeria, Namibia, Uganda, and Zambia.36 In 2016 the pharmaceutical workforce development 
goals (PWDGs) were introduced by the International Pharmaceutical Federation (FIP) to help 
address the critical shortage of pharmacists and expand their use across the health sector. The 
13 different PWDGs focus on a locally-needs based, outcomes-focused approach that span 
across the areas of academia, professional development, and systems to fulfil the vision of 
advancing the pharmaceutical workforce globally.  The PWDGs are intended to be utilized by 
each country independent of socioeconomic status.  
The first of the 13 PWDGs focused on increasing the academic capacity of training 
institutions for both students and the existing workforce. To increase the quality of pharmacy 
education, governments can introduce higher education standards that are appropriately 
assessed through accreditation mechanisms. The Pharmacy Council of India created the 
National Taskforce for Quality Assurance in Pharmacy Education in order to address the 
increasing number of pharmacy institutions with a decreasing number of student applicants.36 
There is also a need to ensure that the training of health workers not only meets higher quality 
standards, but is also relevant for the local needs of the population.37 If pharmacists are over-
qualified for their responsibilities, this could lead to decreased job satisfaction and eventually 
attrition. With gaps in care that span beyond individual disciplines, pharmacists can be trained 
and utilized to help provide public health services in collaboration with other health care 
professionals to provide better care and coverage for patients.  
Case Study: UNC Project-Malawi 
Malawi currently has only one school of pharmacy in Blantyre that trains 40-50 students 
each year. This is not enough to meet the needs of the country. Since 2014, the UNC Eshelman 
School of Pharmacy has been sending students to Lilongwe, Malawi in affiliation with UNC 
Project-Malawi . UNC pharmacy students facilitate the outpatient operations and workflow of 
Kamuzu Central Hospital (KCH) and have the opportunity to help with diabetes and 
cardiovascular screenings in the outpatient clinic. Prior to increased UNC pharmacy 
involvement, KCH had employed only one pharmacist. As of 2017, KCH has now employed a 
total of four pharmacists working in both inpatient and outpatient settings. While most of the 
work focuses on dispensing supervision and supply chain management, there is interest in 
pharmacy expanding into more clinical patient-centered services that have public health 
implications after better understanding how pharmacists could be utilized in this capacity. 
 
MEDICATION SAFETY & ADHERENCE 
Improper medication use is a $500 billion problem worldwide with pharmacists 
positioned to be part of the solution given their medication expertise.38 Having an adequate 
pharmaceutical workforce helps ensure patient safety which is important in the discussion of 
quality being part of the larger global health agenda.39 Substandard and falsified medications 
pose a significant health risk worldwide with poor quality medications often having the wrong 
amount or lack of active ingredient leading to increased morbidity and mortality.  Developing 
countries are impacted the most by falsified and substandard medications where life-saving 
treatments for communicable diseases such as malaria, tuberculosis, and HIV are often the 
targets. A 2012 Lancet study found that up to 35% of antimalarials tested in southeast Asia 
were falsified and that 35% of samples from sub-Saharan Africa failed chemical analysis.40,41 
One study estimates that 122,350 under-five malaria deaths are actually due to the 
consumption of poor quality antimalarials.40 Several factors known to contribute towards poor 
quality medications in which pharmacists can have an impact include self-prescribing behaviors, 
lack of pharmaceutical quality assurance, limited patient knowledge regarding medication 
authenticity, supply chain management, and a lack of regulations to ensure quality control.41 
Pharmacists also have the opportunity to participate in the WHO Prequalification Team which 
helps government agencies ensure the procurement of quality essential medicines.  
Not only are there individual patient issues such as treatment failure, but also public 
health issues including increased incidence and development of drug resistance. A recent WHO 
report indicated that there are too few drugs being developed to address to growing burden of 
multiple drug resistant tuberculosis.42 In addition, a recent meta-analysis of self-medication use 
in developing countries estimates that over 38% of patients self-diagnose and treat which can 
contribute to the growing global burden of antimicrobial resistance.43 Pharmacists are also 
essential to antibiotic stewardship programs which help ensure the rationale use of antibiotics.  
In addition to falsified and substandard medications, medication errors is another global 
medication safety issue that costs $42 billion annually worldwide.44 While automation and 
sophisticated software systems have been in place for quite some time in developed countries 
to mitigate errors, developing countries lack the infrastructure and resources to implement 
such systems. Instead, more basic procedures and paper-based checklists and protocols are 
utilized. In 2007, the WHO launched the High 5’s Patient Safety Initiative aimed at 
implementing and evaluating standardized operating procedures for priority areas such as 
medication reconciliation which can reduce the number of medication errors for patients in 
hospital settings.45 To address the ongoing global health issue of patient safety, the WHO 
launched the third patient safety challenge focusing on the topic of ‘medicines without harm’ 
with an ultimate goal of reducing medication-related harm by 50% over the course of five 
years.46 Pharmacists are again positioned to uniquely contribute to the global health effort of 
patient safety.  
Even if medications are of high quality, they are of limited utility and benefit if patients 
are not adherent. A review of factors positively associated with antimalarial adherence in 
developing countries including individuals with higher household income, higher education, 
provision of information on how to take drugs, and knowledge about malaria and 
antimalarials.43 While pharmacists cannot influence the first two factors, they are critical in 
influencing the latter two. In Malawi and other parts of sub-Saharan Africa, some patients have 
made their own assumptions about the strength or weakness of antimalarial medications  and 
adjust the dosage according to their beliefs.47  Educational implementation strategies have 
been integral in addressing antimicrobial resistance and pharmacists can play a larger role in 
helping shape health behavior.48  
Medication safety is also an influential factor in the recently launched Global Health 
Security Agenda which is a consortium of 31 countries seeking to combat infectious disease 
outbreaks and threats.49. In addition to combatting antimicrobial resistance and falsified drugs, 
the Global Health Security Agenda seeks to restrict the spread of zoonotic diseases through a 
One Health approach, which includes pharmacists. Pharmacists can also be part of biosafety 
and biosecurity efforts by ensuring the proper procurement and administration of medications 
in case of bioterrorism.  
SUPPLY CHAIN MANAGEMENT  
Supply chain management is an area that pharmacists in developing countries as well as 
those working in humanitarian efforts are engaged with in order to help improve access to 
essential medications for both communicable and non-communicable diseases. Each country is 
encouraged by the WHO to develop and use a National Medicines Policy (NMP) which should 
outline strategies and approaches for procuring and using certain medications drawn from the 
Essential Medicines List. Despite 71% of countries having a NMP, less than half of developing 
countries have revised their plan within the past 5 years.50 It is estimated that fewer than 30% 
of patients in the WHO Africa region have public access to essential medications.51 While 
technology and software solutions have helped develop robust supply chain systems in 
developed countries, pharmacists in developing countries such as Haiti are exploring how to 
utilize and implement web-based platforms to mitigate supply chain issues so that more time 
can be spent on patient interaction.52  
Several successful initiatives have been implemented to address shortages of essential 
medications. In 2003, Tanzania with the assistance of Management Sciences for Health (MSH) 
started the Accredited Drug Dispensing Outlet (ADDO) program with the goal of improving 
access to affordable, essential medications. The ADDO program had targeted interventions that 
improved the capabilities of pharmaceutical personnel that worked at the drug outlets and 
imposed new regulations designed to improve medication quality. Evaluation of the ADDO 
program has shown increased adoption of treatment guidelines, significantly higher availability 
of essential medications for children, and increased quality of dispensed medications.53 The 
success of the ADDO program has been replicated in other sub-Saharan countries including 
Uganda and Liberia.  
Case Study: Zambia Health Shops Project 
Currently the Zambia Ministry of Health through the Zambia Medicines Regulatory 
Authority (ZAMRA) is looking to implement the Health Shops Project modeled after the ADDO 
program. While the urban population in Zambia (35%) has access to over 150 pharmacies, 
several rural areas where most of the population lives do not have any access to a pharmacy.54 
This gap in care is filled by illegal drug outlets in which unregulated medications of unknown 
quality are sold and distributed on a transactional basis. The Health Shops Project seeks to 
enforce new regulations and pharmacy training requirements  to provide access to key WHO 
essential medications. The program will be a key example of a public-private partnership in 
order to extend access to care for a larger population that couldn’t be done so by either entity. 
The Health Shops Project will address several of the objectives of the Zambia Health Sector 
Supply Chain Strategy and Implementation Plan (2015-2017) by helping ensure the 
procurement of quality medications as well as their rationale use.55 
Before rolling out country-wide efforts such as the Health Shops Project, it is imperative 
that one assess readiness before doing so. It is estimated that over half of large scale initiatives 
fail due to a lack of planning and readiness assessment.56 Current work is ongoing to help assess 
the readiness of ZAMRA as well as health shop owners to determine what gaps may exists that 
should be addressed as the Health Shops Project is piloted across several rural districts. 
Assessing organizational readiness can then lead to the creation of an implementation blueprint 
to facilitate the scale-up of health shops across districts and eventually the country. This case 
study is a collaboration between the UNC Eshelman School of Pharmacy, UNC Gillings School of 
Global Public Health, and the University of Zambia (UNZA).  
IMMUNIZATIONS 
The launch of the Global Alliance for Vaccine Initiative (GAVI) in 2000 promoted the 
adoption and utilization of vaccines in developing countries at scale. A recent study evaluating 
10 vaccine preventable diseases across 73 low to middle income countries showed that 
vaccination for these diseases could prevent 20 million deaths and over 500 million cases of 
illness between 2001-2020.57 Despite vaccinations being shown to be one of the most cost-
effective public health interventions, developing countries face numerous challenges in 
adopting and sustaining acceptable immunization rates. The WHO Initiative for Vaccine 
Research (IVR) seeks to increases the use of implementation research in order to increase 
adoption of vaccinations in the developing world. Complimenting this effort is the recent launch 
of the Ottawa statement which focuses on population health implementation research with a 
focus on primary prevention programs including immunizations.58 
According to a 2017 assessment report of the WHO Global Vaccine Action Plan, a key 
recommendation moving forward is to broaden the dialogue with other organizations and 
partners, and pharmacists are excellent candidates.59  Over the years policies and regulations in 
the US and other countries have helped pharmacists in other countries gain the necessary 
support to provide key immunizations to promote health and well-being. There is an 
opportunity for pharmacists to do the same in low to middle income countries. More research 
is needed to understand how current immunization implementation plans in developed 
countries, such as the US Department of Health and Human Services National Adult 
Immunization Plan, might be translated to developing countries with the utilization of 
pharmacists. With continued progress towards the development of vaccines against malaria, 
Ebola, and Zika, pharmacists can be positioned to assist with new immunization efforts and 
programs.  
The 2016-2020 GAVI five-year strategy includes four overarching goals including 
increasing the effectiveness and efficiency of immunization delivery.60 Pharmacists are 
positioned to actively contribute towards this effort given their accessibility, therapeutic 
knowledge, and operations management experience. The CDC’s Strategic Framework for Global 
Immunization describes the essential role of the health workforce in ensuring the delivery of 
vaccinations to those who need it.61 Based on the accessibility of pharmacies in developing 
countries where coverage rates for key immunizations are lower, pharmacists can be part of 
immunization screening programs when patients are there to seek medical advice or procure a 
medication.  
MOBILE HEALTH 
Pharmacists can play a significant role in the constantly evolving field of mobile health. 
Over 90% of the world has access to a mobile phone signal which is often much higher than 
access to other services such as sanitation, water, and electricity.62 Combining the accessibility 
of pharmacists with the wide-spectrum coverage of mobile phones presents an emerging 
opportunity. 
The WHO has recognized the importance of determining ways to utilize mobile health 
for non-communicable diseases with the launch of the Be He@lthy, Be Mobile campaign in 
which each WHO Region started a pilot project around one of several disease state areas 
including cervical cancer, diabetes, and tobacco cessation. Pharmacists can be integrated within 
this initiative as they have been with other mHealth programs such as the SMS for Life program 
which has increased access to medications by improving inventory management systems.63 In 
this program pharmacists manage medication inventory by sending SMS text messages to 
district warehouses to indicate supply levels so as to ensure that these medications are 
available to the public. With increased training, pharmacists can extend their role in mHealth by 
using SMS text messages to participate in disease surveillance activities since pharmacists are 
often the first health care professional patients will see. Additionally, pharmacists can utilize 
mHealth to assist with medication safety and adherence issues by sending reminders and 
educational or motivational messages. Known implementation determinants of mHealth 
programs in sub-Saharan Africa include adequate incentives for participation, government 
support and engagement, and appropriate training for clinical staff.64 These determinants can 
help shape future studies as to what are the determinants of participation are of pharmacists in 
these initiatives to combat non-communicable diseases.  
Due to the rapid growth of mHealth, there has been inconsistent terminology use, a 
multitude of new modes and frameworks, and a lack of understanding of what actually 
constitutes mHealth. These challenges make it difficult to compare and synthesize the findings 
of the limited studies being conducted in developing countries around non-communicable 
diseases. If there is standardization of certain design and planning elements of mHealth pilots 
and programs, there could be more effective monitoring and evaluation strategies for the scale 
up of mHealth programs in sub-Saharan African countries.65 Provided that most mHealth 
studies are looking at improving medication adherence, making lifestyle recommendations, or 
changing medication therapy regimens, pharmacists can play a significant role in advancing 
mHealth for non-communicable diseases.  
CHALLENGES FOR PARTICIPATION OF PHARMACISTS IN PUBLIC HEALTH 
Despite the enormous potential for pharmacists to contribute to public health in both 
high and low resource settings, there is still little formal recognition of the ability of pharmacists 
to serve as public health practitioners. In 2006, the American Public Health Association (APHA) 
created a policy statement formally recognizing the role of pharmacists within public health.7 
One of the key insights within the statement was that although pharmacists are performing 
public health activities, their role in public health is not recognized unlike physicians and nurses. 
To strengthen the focus of pharmacists as public health practitioners, the Joint Commission of 
Pharmacy Practitioners, a group of CEOs from the leading US pharmacy associations, developed 
a 2015 vision statement that stated that pharmacists will be prepared for both patient-centered 
and population based care.66 This aligns with the increased training focus on public health 
within the pharmacy curricula. Even with formal recognition, there also appears to be a lack of 
confidence in how pharmacists view their services. In Scotland, only slightly more than half 
either agreed or strongly agreed that they considered themselves as public health practitioners 
despite offering services that would classify them as such.4  
  Also, while organizations within and outside of pharmacy have declared the importance 
of pharmacists in public health, their still needs to be increased awareness and recognition by 
patients of this role. A 2016 report by the Royal Society of Public Health and Public Health 
England stated that a key challenge in establishing the role of the pharmacist in public health 
was that the public lacked awareness of the services pharmacists provide. Only half of the 
public in the United Kingdom knew that pharmacists provided immunizations, family planning, 
and general health checks.67 Although 80% of pharmacy customers in Sweden expected to 
received drug related information from the pharmacist, less than a quarter expected to receive 
information on diet, smoking cessation, or disease management.4 In summary, while 
pharmacists are viewed upon favorably in other countries because of their accessibility and 
convenience, their role impacting public health is not as widely known or understood.68 In 
addition to patient stakeholders, health insurance companies and payers need to recognize 
pharmacists as well so that they can be compensated and incentivized to provide these services 
on a more consistent basis.  
These barriers to recognition are also present in more acute forms in low resource 
settings. Factors known to hinder public health services offered by pharmacists in developing 
countries include a lack of knowledge and skills, lack of confidence, limited policies and 
regulations, poor recognition within the healthcare system, inadequate workforce capacity, and 
patient reluctance to use pharmacy services.26 In Ethiopia nearly 80% and 90% of pharmacy 
personnel were “not at all involved” or “a little involved” in tobacco cessation and diabetes 
management, respectively.26 Often in developing countries there are physical space restrictions 
within community pharmacies making it hard to provide public health services. In Malaysia, 
30% of pharmacies lack a counseling area.11 Another barrier is perceived competency in 
assuming a more public health oriented role. Although aspects of public health are being 
incorporated into training curricula, graduating pharmacists and the existing workforce feel 
insufficiently prepared to delivery such services.11  Additional barriers to advancing the role of 
pharmacist in global public health is a lack of distinct separation from medication prescribing 
and dispensing as well as a critical shortage of pharmacists.17 Even when services are provided, 
there is a high degree of variation concerning the type  and the quality of the service.  
RECOMMENDATIONS 
In summary, while several areas across LMICs progressive growth of pharmacy-based 
public health services, this is not universal. Overall, pharmacists are underutilized within public 
health worldwide and can make an even larger impact on the health of the communities if 
appropriately positioned and recognized. The following policy recommendations are to be 
considered by governments in developing countries in order to enhance the impact that 
existing and future pharmacists can have on global public health. 
1) Recognize pharmacists as part of the public health workforce 
As done in developed countries, formal recognition of pharmacists by associations and the 
governments as part of the public health workforce can provide the confidence needed for 
pharmacists to act as public health practitioners. Further, enhanced recognition at district and 
national levels can increase the visibility of the profession and attract future applicants and 
leaders to enter into pharmacy.  
2) Establish pharmacists’ roles in immunization and medication safety programs that 
promote well-being 
Immunizations are one of the most cost effective interventions, but remain underutilized. 
Pharmacists have been shown to provide safe and effective delivery of immunizations and 
positively influence the behavior of patients receiving the.3 Governments can push for 
pharmacists to be trained as immunizers so as to reduce the already high workload of 
physicians and nurses. A review of training outcomes for healthcare professionals in low to 
middle income countries revealed a number of effective short-term training strategies including 
using train-the-trainer programs in order to upskill the existing workforce.69 
3) Integrate mHealth interventions in community pharmacies 
The accessibility of pharmacists complement the vast accessibility of phones within limited 
resource settings. With the right training, pharmacists can be utilized in mHealth interventions 
that address both communicable and non-communicable diseases. It has already been shown 
how pharmacists can help with supply chain management as in the SMS for Life program and 
this technology can be extended to engage pharmacists in disease surveillance activities as well 
as medication safety and adherence programs.  According to the Global Strategy on Human 
Resources for Health, mHealth tools should be utilized to enhance global public activities such 
as supply chain management and patient safety.35 Government leaders should invest in the 
infrastructure necessary to support the implementation and scale-up of mHealth services which 
can help mitigate the unequal distribute of health workers in rural areas by leveraging 
technology use.  
4) Utilize implementation science methods in pharmacy across limited resource settings  
Many of the above mentioned global health areas have success stories and evidence based 
practices that have been utilized in high income countries. However, it is unknown how 
evidence based practices from the global north translate to the global south. Implementation 
science is the field of understanding how to translate evidence into everyday practice and can 
be utilized across public health issues from medication safety to mobile health. While 
implementation science is stimulating research opportunities in the community and primary 
care settings for pharmacy in the United States, there is a lack of research regarding the 
effective implementation and evaluation of pharmacy services within developing countries. 
There is a need for the appropriate monitoring and evaluation of pharmacy provided public 
health services so that these can be adopted and scaled up accordingly. Implementation 
research for pharmacy in low to middle income countries can help provide the data needed for 
government leaders to support the integration of pharmacists into public health services. As 
pharmacists develop their niche within global public health, there will be the need to 
understand how and why pharmacy services can improve the health and well-being of 
communities throughout the world in resource-limited settings. 
5) Incorporate public health principles in pharmacy education  
There is growing demand by students and pharmacists in developing countries to have 
further instruction and engagement with public health activities so that they can more 
effectively contribute towards the broader health of the community.70 In order to implement 
public health services, students must be appropriately trained in basic public health 
competencies to be able to understand how patients fit into populations and how to manage 
the health of these populations. Beyond key principles of pharmacoepidemiology and health 
policy management, pharmacy students in developing countries should take a primer on 
implementation science that introduces them to the basics of program planning, quality 
improvement, and monitoring and evaluation. This skill set will equip graduates with the 
capability to putting research into practice. Additionally, continuing professional development 
should be offered for those in the workforce to elevate the training of the whole profession. 
This is a need that is also important in high income countries. More schools and colleges 
of pharmacy are developing PharmD/MPH dual degree programs to help prepare individuals 
with the skill sets necessary to be effective in public health programs. The most recent 
accreditation standards for schools and colleges of pharmacy included public health as one of 
the key competencies required for students upon graduation so they can effectively utilize 
population health management strategies and implement public health activities and 
programs.71 Others have called for increased competence across the broader core 
competencies in public health in order for pharmacists to make a larger difference on 
population health.72  
CONCLUSIONS 
Despite the challenges pharmacists face in limited resource settings, the role of the 
pharmacists in global public health in low to middle-income countries will continue to evolve as 
pharmacists become better recognized and engaged in the above mentioned areas. The shift 
pharmacists have made in high-income nations from product-centered to patient-centered 
services with public health implications took decades to achieve. The shift for pharmacists in 
low to middle-income countries will also take time. More studies are required to further 
demonstrate the impact pharmacists can have in resource-limited areas within certain areas of 
global public health. The accumulation of more evidence and data can help drive the 
development of new policies and advocacy efforts to recognize pharmacists not only as patient 
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